105 related articles for article (PubMed ID: 22717024)
1. Post-transplant lymphoproliferative disorder: the significance of central nervous system disease.
Araya CE
Pediatr Transplant; 2012 Sep; 16(6):528-9. PubMed ID: 22717024
[No Abstract] [Full Text] [Related]
2. Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant.
Bonney DK; Htwe EE; Turner A; Kelsey A; Shabani A; Hughes S; Hughes I; Wynn RF
Pediatr Blood Cancer; 2012 Mar; 58(3):459-61. PubMed ID: 21584931
[TBL] [Abstract][Full Text] [Related]
3. Management and outcome of liver recipients with post-transplant lymphoproliferative disease.
Glez-Chamorro A; Jimenez C; Moreno-Glez E; Glez-Pinto I; Loinaz C; Gomez R; Garcia I; Alonso O; Palma F; Grande C
Hepatogastroenterology; 2000; 47(31):211-9. PubMed ID: 10690611
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus infection and lymphoproliferative disorder after hematopoietic cell transplantation.
Zhong Y
Clin J Oncol Nurs; 2012 Apr; 16(2):211-4. PubMed ID: 22459531
[TBL] [Abstract][Full Text] [Related]
5. Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.
Gifford G; Fay K; Jabbour A; Ma DD
Intern Med J; 2015 May; 45(5):583-6. PubMed ID: 25955465
[TBL] [Abstract][Full Text] [Related]
6. Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
Twombley K; Pokala H; Ardura MI; Harker-Murray P; Johnson-Welch SF; Weinberg A; Seikaly M
Pediatr Transplant; 2012 Sep; 16(6):E201-9. PubMed ID: 22646132
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-immunotherapy.
Inoue H; Rai S; Tanaka H; Espinoza JL; Komori-Inoue M; Kakutani H; Minamoto S; Kumode T; Nakayama S; Taniguchi Y; Morita Y; Okuda T; Tatsumi Y; Ashida T; Matsumura I
Viruses; 2020 Apr; 12(4):. PubMed ID: 32276450
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated lymphoproliferative disorder presenting as apparently isolated gastrointestinal lesions in childhood.
Sebire NJ; Malone M; Risdon RA; Ramsay AD
Pediatr Dev Pathol; 2005; 8(1):88-91. PubMed ID: 15717118
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-related lymphoproliferative disorder, cytomegalovirus reactivation, and varicella zoster virus encephalitis during treatment of medulloblastoma.
Ohta M; Taga T; Nomura A; Kato H; Takano T; Maruo Y; Takeuchi Y; Ishida M; Ohta S
J Med Virol; 2011 Sep; 83(9):1582-4. PubMed ID: 21739449
[TBL] [Abstract][Full Text] [Related]
10. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system post-transplantation lymphoproliferative disorder.
Dierickx D; Tousseyn T; Verhoef G
Cancer; 2010 Jul; 116(14):3521; author reply 3521-2. PubMed ID: 20564159
[No Abstract] [Full Text] [Related]
12. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders.
Boratyńska M; Smolska D
Transpl Int; 2008 Jun; 21(6):605-8. PubMed ID: 18282244
[No Abstract] [Full Text] [Related]
13. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
Bar-Natan M; Nagler A
Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060
[No Abstract] [Full Text] [Related]
14. Cytomegalovirus and Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation.
Tsao SY; Chang KC; Chen YP; Yeh YM; Su WC; Chen TY
Ann Hematol; 2011 Jan; 90(1):113-4. PubMed ID: 20369358
[No Abstract] [Full Text] [Related]
15. Post-transplant lymphoproliferative disorders following solid-organ transplantation.
Blaes AH; Morrison VA
Expert Rev Hematol; 2010 Feb; 3(1):35-44. PubMed ID: 21082932
[TBL] [Abstract][Full Text] [Related]
16. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
Zangwill SD; Hsu DT; Kichuk MR; Garvin JH; Stolar CJ; Haddad J; Stylianos S; Michler RE; Chadburn A; Knowles DM; Addonizio LJ
J Heart Lung Transplant; 1998 Dec; 17(12):1161-6. PubMed ID: 9883755
[TBL] [Abstract][Full Text] [Related]
17. Graft rejection in pediatric liver transplant patients with Epstein-Barr viremia and post-transplant lymphoproliferative disease.
Weiner C; Weintraub L; Wistinghausen B; Tomaino J; Arnon R; Kerkar N; Miloh T
Pediatr Transplant; 2012 Aug; 16(5):458-64. PubMed ID: 22554096
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients.
Traum AZ; Rodig NM; Pilichowska ME; Somers MJ
Pediatr Transplant; 2006 Jun; 10(4):505-12. PubMed ID: 16712612
[TBL] [Abstract][Full Text] [Related]
19. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
20. Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patient.
Leaver S; Amlot P; Thuraisingham R; Norton A; Aitken C; Cavenagh JD
Clin Lab Haematol; 2004 Oct; 26(5):351-3. PubMed ID: 15485466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
